PFE:NYE-Pfizer Inc (USD)

COMMON STOCK | Drug Manufacturers - General |

Last Closing

USD 26.3

Change

+0.40 (+1.54)%

Market Cap

USD 150.29B

Volume

0.05B

Analyst Target

USD 41.79
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-21 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
LLY Eli Lilly and Company

+0.56 (+0.06%)

USD 789.88B
NVO Novo Nordisk A/S

+4.34 (+5.18%)

USD 382.35B
JNJ Johnson & Johnson

+2.62 (+1.64%)

USD 368.65B
ABBV AbbVie Inc

+1.20 (+0.60%)

USD 340.83B
AZN AstraZeneca PLC ADR

-0.34 (-0.46%)

USD 228.18B
BMY Bristol-Myers Squibb Company

+0.04 (+0.07%)

USD 109.38B
OGN Organon & Co

-0.20 (-1.27%)

USD 3.77B
NVS Novartis AG ADR

+2.04 (+1.90%)

N/A
GSK GlaxoSmithKline PLC ADR

-0.32 (-0.87%)

N/A
MRK Merck & Company Inc

+1.82 (+2.08%)

N/A

ETFs Containing PFE

FTXH First Trust Nasdaq Pharma.. 6.85 % 0.60 %

+0.12 (+-1.47%)

USD 0.02B
THNR Amplify ETF Trust 5.53 % 0.00 %

+0.14 (+-1.47%)

USD 4.17M
LIFE-U:CA Evolve Global Healthcare .. 5.25 % 0.00 %

N/A

N/A
LIFE-B:CA Evolve Global Healthcare .. 5.06 % 0.00 %

+0.34 (+-1.47%)

N/A
HART IQ Healthy Hearts ETF 4.99 % 0.00 %

+0.02 (+-1.47%)

USD 9.76M
TDIV:SW VanEck Morningstar Develo.. 4.86 % 0.00 %

+0.07 (+-1.47%)

USD 1.33B
HVAX:CA 4.81 % 0.00 %

N/A

N/A
ZWHC:CA BMO Covered Call Health C.. 4.71 % 0.00 %

+0.42 (+-1.47%)

N/A
TDGB:LSE VanEck Morningstar Develo.. 4.66 % 0.00 %

+0.08 (+-1.47%)

USD 1.33B
TDIV:LSE VanEck Morningstar Develo.. 4.46 % 0.00 %

+0.11 (+-1.47%)

N/A
ZWH:CA BMO US High Dividend Cove.. 4.32 % 0.71 %

-0.03 (-1.47%)

CAD 1.06B
SCHD Schwab U.S. Dividend Equi.. 4.20 % 0.07 %

-0.11 (-1.47%)

USD 68.08B
MEDX Horizon Kinetics Medical .. 4.08 % 0.00 %

+0.07 (+-1.47%)

N/A
DVOP 4.04 % 0.00 %

N/A

N/A
NXTV Simplify Next Intangible .. 3.70 % 0.00 %

-0.40 (-1.47%)

USD 1.33M
OZEM Roundhill GLP-1 & Weight .. 3.54 % 0.00 %

+0.28 (+-1.47%)

USD 0.04B
HEAL:CA 3.29 % 0.00 %

N/A

N/A
UVAL:SW SPDR® MSCI USA Value UCI.. 3.11 % 0.00 %

-0.11 (-1.47%)

USD 0.15B
PEY Invesco High Yield Equity.. 3.09 % 0.53 %

-0.13 (-1.47%)

USD 1.21B
SXLV:SW SPDR S&P U.S. Health Care.. 2.99 % 0.00 %

-0.03 (-1.47%)

N/A
IUHC:SW iShares S&P 500 Health Ca.. 2.95 % 0.00 %

-0.04 (-1.47%)

N/A
GXLV:LSE SPDR® S&P® U.S. Health .. 2.94 % 0.00 %

-0.10 (-1.47%)

N/A
CDNA:CA CI Bio-Revolution Index E.. 2.81 % 0.00 %

-0.06 (-1.47%)

CAD 6.78M
SPHD Invesco S&P 500® High Di.. 2.65 % 0.30 %

+0.18 (+-1.47%)

USD 3.37B
WMOT:XETRA 2.56 % 0.00 %

N/A

N/A
ZDY:CA BMO US Dividend ETF (CAD) 2.42 % 0.32 %

-0.12 (-1.47%)

CAD 0.63B
IUVL:SW iShares Edge MSCI USA Val.. 2.33 % 0.00 %

N/A

USD 1.86B
H41D:XETRA 2.17 % 0.00 %

N/A

N/A
CBUI:XETRA 2.08 % 0.00 %

N/A

N/A
VLUE:AU VanEck MSCI International.. 2.08 % 0.00 %

-0.06 (-1.47%)

N/A
JHDV John Hancock Exchange Tra.. 2.00 % 0.00 %

-0.52 (-1.47%)

N/A
BTC Grayscale Bitcoin Mini Tr.. 1.98 % 0.00 %

-1.64 (-1.47%)

N/A
HWVS:LSE HSBC MSCI World Value ESG.. 1.93 % 0.00 %

-0.02 (-1.47%)

USD 0.23B
GEDV:LSE SPDR® S&P® Global Divid.. 1.84 % 0.00 %

+0.20 (+-1.47%)

USD 0.02B
ZPD3:XETRA 1.84 % 0.00 %

N/A

N/A
GLDVD:SW UBS (Irl) ETF plc - S&P D.. 1.79 % 0.00 %

+0.02 (+-1.47%)

USD 0.11B
DIVG Invesco Exchange-Traded F.. 1.69 % 0.00 %

-0.16 (-1.47%)

USD 3.13M
BSCJ 0.85 % 0.10 %

N/A

N/A
JEST:SW JPM EUR Ultra-Short Incom.. 0.73 % 0.00 %

+0.10 (+-1.47%)

USD 0.96B
XEXP:CA iShares Exponential Techn.. 0.55 % 0.00 %

-0.19 (-1.47%)

CAD 0.02B
SYBS:F 0.39 % 0.00 %

N/A

N/A
SYBS:XETRA 0.39 % 0.00 %

N/A

N/A
XDEE:XETRA 0.22 % 0.00 %

N/A

N/A
XDED:XETRA 0.22 % 0.00 %

N/A

N/A
XDEW:SW Xtrackers S&P 500 Equal W.. 0.22 % 0.00 %

-0.74 (-1.47%)

USD 13.42B
SP2D:XETRA 0.22 % 0.00 %

N/A

N/A
SP2Q:XETRA 0.22 % 0.00 %

N/A

N/A
QUS:AU BetaShares S&P 500 Equal .. 0.22 % 0.00 %

-0.35 (-1.47%)

USD 0.77B
CYH:CA iShares Global Monthly Di.. 0.00 % 0.66 %

-0.06 (-1.47%)

CAD 0.14B
DEW WisdomTree Global High Di.. 0.00 % 0.58 %

-0.31 (-1.47%)

N/A
DIVY Tidal ETF Trust 0.00 % 0.85 %

-0.16 (-1.47%)

USD 0.01B
DVY iShares Select Dividend E.. 0.00 % 0.39 %

-0.62 (-1.47%)

N/A
FDL First Trust Morningstar D.. 0.00 % 0.45 %

+0.02 (+-1.47%)

N/A
GNRX 0.00 % 0.55 %

N/A

N/A
IBDK 0.00 % 0.10 %

N/A

N/A
IHE iShares U.S. Pharmaceutic.. 0.00 % 0.42 %

+0.42 (+-1.47%)

N/A
IOO iShares Global 100 ETF 0.00 % 0.40 %

-1.41 (-1.47%)

N/A
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

-0.34 (-1.47%)

N/A
JHMH 0.00 % 0.46 %

N/A

N/A
MOAT VanEck Morningstar Wide M.. 0.00 % 0.49 %

-0.68 (-1.47%)

N/A
MUS:CA 0.00 % 0.58 %

N/A

N/A
PEU.B:CA 0.00 % 1.16 %

N/A

N/A
PILL Direxion Daily Pharmaceut.. 0.00 % 0.98 %

-0.11 (-1.47%)

N/A
PJP Invesco Dynamic Pharmaceu.. 0.00 % 0.56 %

-0.33 (-1.47%)

N/A
QDYN 0.00 % 0.37 %

N/A

N/A
RDIV Invesco S&P Ultra Dividen.. 0.00 % 0.39 %

-0.46 (-1.47%)

N/A
RBUS 0.00 % 0.30 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

+0.04 (+-1.47%)

CAD 0.10B
DURA VanEck Morningstar Durabl.. 0.00 % 0.00 %

N/A

USD 0.05B
RWDC 0.00 % 0.00 %

N/A

N/A
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

N/A

CAD 0.05B
PEU-B:CA 0.00 % 0.00 %

N/A

N/A
HID-B:CA 0.00 % 0.00 %

N/A

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

+0.17 (+-1.47%)

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

+0.17 (+-1.47%)

N/A
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

-0.50 (-1.47%)

N/A
SHU:CA 0.00 % 0.70 %

N/A

N/A
SICK 0.00 % 0.95 %

N/A

N/A
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

-2.09 (-1.47%)

N/A
VLUE iShares MSCI USA Value Fa.. 0.00 % 0.15 %

-1.74 (-1.47%)

USD 7.21B
XHC:CA iShares Global Healthcare.. 0.00 % 0.65 %

-0.06 (-1.47%)

CAD 0.56B
XPH SPDR® S&P Pharmaceutical.. 0.00 % 0.35 %

-0.22 (-1.47%)

N/A
DGR:CA 0.00 % 0.43 %

N/A

N/A
DFU:CA 0.00 % 0.59 %

N/A

N/A
XDGH:CA iShares Core MSCI Global .. 0.00 % 0.22 %

+0.08 (+-1.47%)

CAD 0.08B
XDUH:CA iShares Core MSCI US Qual.. 0.00 % 0.15 %

+0.08 (+-1.47%)

CAD 0.05B
ZVU:CA BMO MSCI USA Value ETF 0.00 % 0.33 %

-0.43 (-1.47%)

CAD 0.06B
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.69 %

+0.15 (+-1.47%)

CAD 0.22B
GBDV:LSE SPDR S&P Global Dividend .. 0.00 % 0.00 %

+0.07 (+-1.47%)

N/A
GLDV:LSE SSgA SPDR ETFs Europe I P.. 0.00 % 0.00 %

+0.26 (+-1.47%)

N/A
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

-2.00 (-1.47%)

N/A
IUVD:LSE iShares Edge MSCI USA Val.. 0.00 % 0.00 %

-0.01 (-1.47%)

USD 0.33B
IUVF:LSE iShares Edge MSCI USA Val.. 0.00 % 0.00 %

-0.25 (-1.47%)

USD 1.87B
IUVL:LSE iShares Edge MSCI USA Val.. 0.00 % 0.00 %

-0.01 (-1.47%)

USD 1.89B
ISXF:LSE iShares Corporate Bond ex.. 0.00 % 0.00 %

+0.20 (+-1.47%)

USD 0.07B
LUMV:LSE Ossiam US Minimum Varianc.. 0.00 % 0.00 %

+105.00 (+-1.47%)

N/A
SLXX:LSE iShares Core £ Corp Bond.. 0.00 % 0.00 %

+0.20 (+-1.47%)

N/A
SSXF:LSE iShares III Public Limite.. 0.00 % 0.00 %

+0.47 (+-1.47%)

N/A
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

-0.12 (-1.47%)

N/A
USMV:LSE Ossiam US Minimum Varianc.. 0.00 % 0.00 %

+1.43 (+-1.47%)

USD 9.94M
UVAL:LSE SPDR® MSCI USA Value UCI.. 0.00 % 0.00 %

-0.17 (-1.47%)

USD 0.14B
VVAL:LSE 0.00 % 0.00 %

N/A

N/A
WHEA:LSE SPDR® MSCI World Health .. 0.00 % 0.00 %

+0.09 (+-1.47%)

N/A
XDEV:LSE Xtrackers MSCI World Valu.. 0.00 % 0.00 %

-1.00 (-1.47%)

N/A
XDND:LSE 0.00 % 0.00 %

N/A

N/A
XDWH:LSE Xtrackers MSCI World Heal.. 0.00 % 0.00 %

+0.09 (+-1.47%)

N/A
ZISG:LSE 0.00 % 0.00 %

N/A

N/A
USVL:LSE SPDR® MSCI USA Value UCI.. 0.00 % 0.00 %

-0.19 (-1.47%)

USD 0.14B
XSSX:LSE Xtrackers - Euro Stoxx 50.. 0.00 % 0.00 %

-1.45 (-1.47%)

USD 0.04B
ZILS:LSE 0.00 % 0.00 %

N/A

N/A
MVUS:PA 0.00 % 0.00 %

N/A

N/A
MWO:PA Amundi FTSE EPRA/NAREIT G.. 0.00 % 0.00 %

-0.31 (-1.47%)

USD 0.10B
SPMV:PA 0.00 % 0.00 %

N/A

N/A
DXS3:F 0.00 % 0.00 %

N/A

N/A
EXX5:F 0.00 % 0.00 %

N/A

N/A
IS3S:F 0.00 % 0.00 %

N/A

N/A
JEST:F 0.00 % 0.00 %

N/A

N/A
LMWE:F 0.00 % 0.00 %

N/A

N/A
OSX2:F 0.00 % 0.00 %

N/A

N/A
QDVG:F 0.00 % 0.00 %

N/A

N/A
QDVI:F 0.00 % 0.00 %

N/A

N/A
UBUM:F 0.00 % 0.00 %

N/A

N/A
XDEW:F 0.00 % 0.00 %

N/A

N/A
XGLF:F 0.00 % 0.00 %

N/A

N/A
XUHC:F 0.00 % 0.00 %

N/A

N/A
ZPDH:F 0.00 % 0.00 %

N/A

N/A
ZPRU:F 0.00 % 0.00 %

N/A

N/A
XMDU:F 0.00 % 0.00 %

N/A

N/A
DXSP:XETRA 0.00 % 0.00 %

N/A

N/A
JEST:XETRA 0.00 % 0.00 %

N/A

N/A
LMWE:XETRA 0.00 % 0.00 %

N/A

N/A
OSX2:XETRA 0.00 % 0.00 %

N/A

N/A
QDVG:XETRA 0.00 % 0.00 %

N/A

N/A
QDVI:XETRA 0.00 % 0.00 %

N/A

N/A
UBUM:XETRA 0.00 % 0.00 %

N/A

N/A
XDEW:XETRA 0.00 % 0.00 %

N/A

N/A
XGLF:XETRA 0.00 % 0.00 %

N/A

N/A
XUHC:XETRA 0.00 % 0.00 %

N/A

N/A
UIQM:XETRA 0.00 % 0.00 %

N/A

N/A
XMDU:XETRA 0.00 % 0.00 %

N/A

N/A
ZPDH:XETRA 0.00 % 0.00 %

N/A

N/A
ZPRU:XETRA 0.00 % 0.00 %

N/A

N/A
HIG-U:CA 0.00 % 0.00 %

N/A

N/A
USDY 0.00 % 0.00 %

N/A

N/A
GBDV 0.00 % 0.00 %

N/A

N/A
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
IXJ:AU iShares Global Healthcare.. 0.00 % 0.00 %

+0.43 (+-1.47%)

USD 1.43B
QMJ 0.00 % 0.00 %

N/A

N/A
RAFE PIMCO RAFI ESG U.S. ETF P.. 0.00 % 0.00 %

-0.45 (-1.47%)

USD 0.08B
HKND Humankind Benefit Corpora.. 0.00 % 0.00 %

-0.22 (-1.47%)

USD 0.16B
HEAW:LSE SPDR® MSCI World Health .. 0.00 % 0.00 %

-0.02 (-1.47%)

N/A
XWVS:LSE Xtrackers MSCI World Valu.. 0.00 % 0.00 %

-0.02 (-1.47%)

USD 8.61M

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.87% 27% F 28% F
Dividend Return 1.62% 100% F 78% C+
Total Return 0.75% 27% F 39% F
Trailing 12 Months  
Capital Gain -5.26% 45% F 23% F
Dividend Return 6.09% 100% F 78% C+
Total Return 0.83% 45% F 26% F
Trailing 5 Years  
Capital Gain -22.40% 10% F 25% F
Dividend Return 23.58% 80% B- 72% C
Total Return 1.19% 10% F 30% F
Average Annual (5 Year Horizon)  
Capital Gain -3.08% 18% F 18% F
Dividend Return 0.60% 18% F 24% F
Total Return 3.68% 73% C 71% C-
Risk Return Profile  
Volatility (Standard Deviation) 26.68% 27% F 40% F
Risk Adjusted Return 2.25% 18% F 22% F
Market Capitalization 150.29B 38% F 99% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector